ARTICLE | Company News
Neurocrine receives GSK milestone
October 29, 2001 8:00 AM UTC
NBIX received a $15.5 million milestone from GlaxoSmithKline (GSK; LSE:GSK) of $15.5 million - the first under the company's July deal to develop and market corticotropin releasing factor receptor ant...